169 related articles for article (PubMed ID: 36194675)
21. Purity of transferred CD8(+) T cells is crucial for safety and efficacy of combinatorial tumor immunotherapy in the absence of SHP-1.
Watson HA; Dolton G; Ohme J; Ladell K; Vigar M; Wehenkel S; Hindley J; Mohammed RN; Miners K; Luckwell RA; Price DA; Matthews RJ; Ager A
Immunol Cell Biol; 2016 Sep; 94(8):802-8. PubMed ID: 27430370
[TBL] [Abstract][Full Text] [Related]
22. Suppression of proximal T cell receptor signaling and lytic function in CD8+ tumor-infiltrating T cells.
Monu N; Frey AB
Cancer Res; 2007 Dec; 67(23):11447-54. PubMed ID: 18056473
[TBL] [Abstract][Full Text] [Related]
23. SHP-1 in T cells limits the production of CD8 effector cells without impacting the formation of long-lived central memory cells.
Fowler CC; Pao LI; Blattman JN; Greenberg PD
J Immunol; 2010 Sep; 185(6):3256-67. PubMed ID: 20696858
[TBL] [Abstract][Full Text] [Related]
24. Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells.
Liu CY; Chen KF; Chao TI; Chu PY; Huang CT; Huang TT; Yang HP; Wang WL; Lee CH; Lau KY; Tsai WC; Su JC; Wu CY; Chen MH; Shiau CW; Tseng LM
J Mol Med (Berl); 2017 Sep; 95(9):965-975. PubMed ID: 28578456
[TBL] [Abstract][Full Text] [Related]
25. SHP-1 ameliorates nonalcoholic steatohepatitis by inhibiting proinflammatory cytokine production.
Lin L; Jian J; Song CY; Chen F; Ding K; Xie WF; Hu PF
FEBS Lett; 2020 Sep; 594(18):2965-2974. PubMed ID: 32619269
[TBL] [Abstract][Full Text] [Related]
26. A differential gene expression study: Ptpn6 (SHP-1)-insufficiency leads to neutrophilic dermatosis-like disease (NDLD) in mice.
Nesterovitch AB; Arbieva Z; Toth DM; Tharp MD; Glant TT
J Dermatol Sci; 2016 Jul; 83(1):17-25. PubMed ID: 27020408
[TBL] [Abstract][Full Text] [Related]
27. Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8
Peng DH; Rodriguez BL; Diao L; Chen L; Wang J; Byers LA; Wei Y; Chapman HA; Yamauchi M; Behrens C; Raso G; Soto LMS; Cuentes ERP; Wistuba II; Kurie JM; Gibbons DL
Nat Commun; 2020 Sep; 11(1):4520. PubMed ID: 32908154
[TBL] [Abstract][Full Text] [Related]
28. Tumour targetable and microenvironment-responsive nanoparticles simultaneously disrupt the PD-1/PD-L1 pathway and MAPK/ERK/JNK pathway for efficient treatment of colorectal cancer.
Li Y; Qi M; Ding F; Lv Y; Ma J; Zhu Y
J Drug Target; 2021 Apr; 29(4):454-465. PubMed ID: 33233956
[TBL] [Abstract][Full Text] [Related]
29. SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression.
Wen LZ; Ding K; Wang ZR; Ding CH; Lei SJ; Liu JP; Yin C; Hu PF; Ding J; Chen WS; Zhang X; Xie WF
Cancer Res; 2018 Aug; 78(16):4680-4691. PubMed ID: 29776962
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders.
Capello D; Deambrogi C; Rossi D; Lischetti T; Piranda D; Cerri M; Spina V; Rasi S; Gaidano G; Lunghi M
Br J Haematol; 2008 May; 141(4):504-11. PubMed ID: 18318760
[TBL] [Abstract][Full Text] [Related]
31. PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas.
Sooman L; Ekman S; Tsakonas G; Jaiswal A; Navani S; Edqvist PH; Pontén F; Bergström S; Johansson M; Wu X; Blomquist E; Bergqvist M; Gullbo J; Lennartsson J
Tumour Biol; 2014 May; 35(5):4479-88. PubMed ID: 24510345
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of SHP-1 Expands the Repertoire of Antitumor T Cells Available to Respond to Immune Checkpoint Blockade.
Snook JP; Soedel AJ; Ekiz HA; O'Connell RM; Williams MA
Cancer Immunol Res; 2020 Apr; 8(4):506-517. PubMed ID: 32075800
[TBL] [Abstract][Full Text] [Related]
33. SHP-1 is directly activated by the aryl hydrocarbon receptor and regulates BCL-6 in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Phadnis-Moghe AS; Li J; Crawford RB; Kaminski NE
Toxicol Appl Pharmacol; 2016 Nov; 310():41-50. PubMed ID: 27546522
[TBL] [Abstract][Full Text] [Related]
34. Research on the epigenetic regulation mechanism of the PTPN6 gene in advanced chronic myeloid leukaemia.
Zhang X; Yang L; Liu X; Nie Z; Wang X; Pan Y; Luo J
Br J Haematol; 2017 Sep; 178(5):728-738. PubMed ID: 28480959
[TBL] [Abstract][Full Text] [Related]
35. Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions.
Garcia-Bates TM; Palma ML; Shen C; Gambotto A; Macatangay BJC; Ferris RL; Rinaldo CR; Mailliard RB
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541848
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors.
Kang X; Kim J; Deng M; John S; Chen H; Wu G; Phan H; Zhang CC
Cell Cycle; 2016; 15(1):25-40. PubMed ID: 26636629
[TBL] [Abstract][Full Text] [Related]
37. Cutting Edge: Dysregulated CARD9 Signaling in Neutrophils Drives Inflammation in a Mouse Model of Neutrophilic Dermatoses.
Tartey S; Gurung P; Samir P; Burton A; Kanneganti TD
J Immunol; 2018 Sep; 201(6):1639-1644. PubMed ID: 30082320
[TBL] [Abstract][Full Text] [Related]
38. SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation.
Chemnitz JM; Parry RV; Nichols KE; June CH; Riley JL
J Immunol; 2004 Jul; 173(2):945-54. PubMed ID: 15240681
[TBL] [Abstract][Full Text] [Related]
39. Squamous cell carcinomas escape immune surveillance via inducing chronic activation and exhaustion of CD8+ T Cells co-expressing PD-1 and LAG-3 inhibitory receptors.
Mishra AK; Kadoishi T; Wang X; Driver E; Chen Z; Wang XJ; Wang JH
Oncotarget; 2016 Dec; 7(49):81341-81356. PubMed ID: 27835902
[TBL] [Abstract][Full Text] [Related]
40. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
